These emerging medications , including Wegovy, Tirzepatide , and Zaxig , represent a significant advancement in addressing type 2 diabetes and supporting weight reduction . They operate by imitating the body’s natural incretin signal , helping to moderate blood glucose and lower hunger . The drug